HLA-class I expression in gastric cancer

Journal of Surgical Oncology

Volumn 97, Issue 7, 2008, Pages 605-608

  Ishigami, Sumiya ^a,b   Natsugoe, Shoji ^a   Nakajo, Akihiro ^a   Arigami, Takaaki ^a   Kitazono, Masaki ^a   Okumura, Hiroshi ^a   Matsumoto, Masataka ^a   Uchikado, Yasuto ^a   Setoyama, Tetsuro ^a   Sasaki, Ken ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Depth of invasion; Gastric cancer; Histology; HLA class I; Nodal involvement; Prognosis

Indexed keywords

HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CYTOTOXIC T LYMPHOCYTE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STOMACH CANCER; TUMOR ESCAPE;

EID: 44849130514     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21029     Document Type: Article

References (20)

1. de Vries JE, Spits H: Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol 1984;132:510-519.
2. Maryanski JL, Pala P, Corradin G, et al.: H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 1986;324:578-579.
3. Kang X, Kawakami Y, el-Gamil M, et al.: Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol 1995;155:1343-1348.
4. Suzuki K, Sahara H, Okada Y, et al.: Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes. J Immunol 1999;163:2783-2791.
5. Rees RC, Mian S: Selective MHC expression in tumours modulates adaptive and innate antitumour responses. Cancer Immunol Immunother 1999;48:374-381.
6. Bubeník J: Tumour MHC class I downregulation and immunotherapy (Review). Oncol Rep 2003;10:2005-2008.
7. Dierssen JW, de Miranda NF, Ferrone S, et al.: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA-class I expression. BMC Cancer 2007:7:33.
8. Nie Y, Yang G, Song Y, et al.: DNA hypermethylation is a mechanism for loss of expression of the HLA-class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001;22:1615-1623.
9. Menon AG, Morreau H, Tollenaar RA, et al.: Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients. Lab Invest 2002;82:1725-1733.
10. Speetjens FM, de Bruin EC, Morreau H, et al.: Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother 2008;57:601-609.
11. Hirata T, Yamamoto H, Taniguchi H, et al.: Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability. J Pathol 2007:211:516-523.
12. Wang XC, Zhang JQ, Shen YQ, et al.: Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. J Exp Clin Cancer Res 2006;25:115-119.
13. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998;1:10-24.
14. Tsukahara T, Kawaguchi S, Torigoe T, et al.: Prognostic significance of HLA-class I expression in osteosarcoma defined by anti-pan HLA-class I monoclonal antibody, EM R8-5. Cancer Sci 2006;97:1374-1380.
15. Kitamura H, Honma I, Torigoe T, et al.: Down-regulation of HLA-class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. J Urol 2007;177:1269-1272.
16. Ishigami S, Aikou T, Natsugoe S, et al.: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998;55:65-69.
17. Ishii N, Chiba M, Iizuka M, et al.: Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on human gastric epithelium. Gastroenterol Jpn 1992;27:23-28.
18. Chiba M, Ishii N, Ishioka T, et al.: Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium. J Gastroenterol 1995;30:149-155.
19. Panetta A, Martoni A, Guaraldi M, et al.: Combined chemo-immuno- hormonotherapy of advanced renal cell carcinoma. J Chemother 1994;6:349-353.
20. Hoshino T, Seki N, Kikuchi M, et al.: HLA-class I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer. Int J Cancer 1997;70:631-638.